- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Granules India Limited — Updates, 31-03-2026: Press Release
31-03-2026 | 11:39 am
31-03-2026 | 11:39 am
Granules' subsidiary, Granules Life Sciences, successfully concluded a US FDA inspection with a Voluntary Action Indicated (VAI) classification, meaning no regulatory action is required. This boosts multi-site manufacturing capabilities for approved products.
No comments yet. Be the first to comment!